Peptide-based synthetic vaccines

This review summarise the current stand and future perspective on synthetic peptide-based vaccines.

• Publication year

  2015

• Venue

  Chemical Science

• Publication date

  2015-12-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1039/c5sc03892hPMID 28791117PMCID 5529997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The ins and outs of MHC class II-mediated antigen processing and presentation

  2015cited by this paper
• Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC)

  2015cited by this paper
• New approaches to HIV vaccine development.

  2015cited by this paper
• A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate.

  2015cited by this paper
• Polyacrylate-based delivery system for self-adjuvanting anticancer peptide vaccine.

  2015cited by this paper
• Convergent chemo-enzymatic synthesis of mannosylated glycopeptides; targeting of putative vaccine candidates to antigen presenting cells

  2015cited by this paper
• The use of a conformational cathepsin D-derived epitope for vaccine development against Schistosoma mansoni.

  2015cited by this paper
• Ovalbumin lipid core peptide vaccines and their CD4(+) and CD8(+) T cell responses.

  2014cited by this paper
• Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine.

  2014cited by this paper
• Therapeutic vaccines for cancer: an overview of clinical trials

  2014cited by this paper
• Oxime ligation: a chemoselective click-type reaction for accessing multifunctional biomolecular constructs.

  2014cited by this paper
• Peptide-based vaccines for cancer therapy

  2014cited by this paper
• Stapled HIV-1 Peptides Recapitulate Antigenic Structures and Engage Broadly Neutralizing Antibodies

  2014cited by this paper
• Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release

  2014cited by this paper
• Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccines.

  2014cited by this paper
• Oral delivery of nanoparticle-based vaccines

  2014cited by this paper
• Recent progress in adjuvant discovery for peptide-based subunit vaccines

  2014cited by this paper
• Peptide Vaccine: Progress and Challenges

  2014cited by this paper
• Recent advances in peptide-based subunit nanovaccines.

  2014cited by this paper
• Liposomes as nanovaccine delivery systems.

  2014cited by this paper
• Physicochemical Properties of Nanomaterials: Implication in Associated Toxic Manifestations

  2014cited by this paper
• Toll-like receptor agonists: a patent review (2011 – 2013)

  2014cited by this paper
• Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose

  2013cited by this paper
• Self-adjuvanting polymer-peptide conjugates as therapeutic vaccine candidates against cervical cancer.

  2013cited by this paper
• Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles.

  2013cited by this paper
• Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine

  2013cited by this paper
• Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

  2013cited by this paper
• Key roles of adjuvants in modern vaccines

  2013cited by this paper
• Fully synthetic self-adjuvanting thioether-conjugated glycopeptide-lipopeptide antitumor vaccines for the induction of complement-dependent cytotoxicity against tumor cells.

  2013cited by this paper
• Advances in T-Cell Epitope Engineering

  2013cited by this paper
• The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.

  2013cited by this paper
• Monovalent and Multivalent Ligation of the B Cell Receptor Exhibit Differential Dependence upon Syk and Src Family Kinases

  2013cited by this paper
• Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T‐cell activation

  2013cited by this paper
• Fundamental roles of the innate-like repertoire of natural antibodies in immune homeostasis

  2013cited by this paper
• A peptide's perspective on antigen presentation to the immune system.

  2013cited by this paper
• An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development system.

  2013cited by this paper
• A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells

  2013cited by this paper
• Influence of conjugation chemistry and B epitope orientation on the immune response of branched peptide antigens.

  2013cited by this paper
• Water-soluble polymers coupled with glycopeptide antigens and T-cell epitopes as potential antitumor vaccines.

  2013cited by this paper
• Antiadhesin Peptide-Based Vaccines for Pseudomonas aeruginosa

  2013cited by this paper
• Modern Subunit Vaccines: Development, Components, and Research Opportunities

  2013cited by this paper
• Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo.

  2013cited by this paper
• Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation.

  2013cited by this paper
• Nanoparticle hydrophobicity dictates immune response.

  2012cited by this paper
• Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland

  2012cited by this paper
• Liposome-based delivery system for vaccine candidates: constructing an effective formulation.

  2012cited by this paper
• Convergent Synthesis of Glycodendropeptides by Click Chemistry Approaches

  2012cited by this paper
• Cross-presentation by dendritic cells

  2012cited by this paper
• Biomineralization and size control of stable calcium phosphate core-protein shell nanoparticles: potential for vaccine applications.

  2012cited by this paper
• HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes

  2012cited by this paper
• Advances in peptide-based human papillomavirus therapeutic vaccines.

  2012cited by this paper
• Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths.

  2012cited by this paper
• Reverse thioether ligation route to multimeric peptide antigens.

  2012cited by this paper
• Engineered Synthetic Virus‐Like Particles and Their Use in Vaccine Delivery

  2011cited by this paper
• Towards a systems understanding of MHC class I and MHC class II antigen presentation

  2011cited by this paper
• Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation.

  2011cited by this paper
• Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method.

  2011cited by this paper
• Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses.

  2011cited by this paper
• Peptide-based subunit nanovaccines.

  2011cited by this paper
• Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis.

  2010cited by this paper
• Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide

  2010cited by this paper
• Research Article: Synthetic Peptide Vaccine Development: Designing Dual Epitopes into a Single Pilin Peptide Immunogen Generates Antibody Cross‐reactivity between Two Strains of Pseudomonas aeruginosa

  2010cited by this paper
• Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system.

  2010cited by this paper
• Group A streptococcal vaccines: facts versus fantasy

  2009cited by this paper
• Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

  2009cited by this paper
• Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads.

  2008cited by this paper
• B-cell epitope engineering: A matter of recognizing protein features and motives.

  2008cited by this paper
• Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina.

  2008cited by this paper
• Targeting of Antigen to Dendritic Cells with Poly(γ-Glutamic Acid) Nanoparticles Induces Antigen-Specific Humoral and Cellular Immunity1

  2007cited by this paper
• Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.

  2007cited by this paper
• More than one reason to rethink the use of peptides in vaccine design

  2007cited by this paper
• Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.

  2007cited by this paper
• Exploiting lymphatic transport and complement activation in nanoparticle vaccines

  2007cited by this paper
• Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

  2007cited by this paper
• Animal protection and structural studies of a consensus sequence vaccine targeting the receptor binding domain of the type IV pilus of Pseudomonas aeruginosa.

  2007cited by this paper
• Pathogen recognition and development of particulate vaccines: does size matter?

  2006cited by this paper
• Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.

  2006cited by this paper
• Method for the synthesis of multi-epitopic Streptococcus pyogenes lipopeptide vaccines using native chemical ligation.

  2006cited by this paper
• The success and failure of BCG — implications for a novel tuberculosis vaccine

  2005cited by this paper
• ISCOMTM‐based vaccines: The second decade

  2005cited by this paper
• Helper T cells, dendritic cells and CTL Immunity

  2004cited by this paper
• Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery.

  2004cited by this paper
• Vaccine adjuvants: Current state and future trends

  2004cited by this paper
• Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection.

  2003cited by this paper
• Simultaneous lipidation of a characterized peptide mixture by chemoselective ligation.

  2003cited by this paper
• HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.

  2003cited by this paper
• Type 1/Type 2 immunity in infectious diseases.

  2001cited by this paper
• Th1 and Th2 responses: what are they?

  2000cited by this paper
• New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population

  2000cited by this paper
• Immunization of mice with peptomers covalently coupled to aluminum oxide nanoparticles.

  1999cited by this paper
• The Journal of

  1998cited by this paper
• Mapping of conformational B cell epitopes within alpha-helical coiled coil proteins.

  1997cited by this paper
• Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction

  1995cited by this paper
• Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

  1994cited by this paper
• Peptide‐induced memory (IgG) response, cross‐reactive with native proteins, requires covalent linkage of a specific B cell epitope with a T cell epitope

  1993cited by this paper
• Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

  1988cited by this paper

• Constructing the Active Sites of an Artificial Hydrolase Using Mercaptoethanol as a Destructive Agent

  2026influential citation
• Targeting mycobacterial PPE65 protein to develop a multi-epitope vaccine candidate against tuberculosis.

  2026cites this paper
• Reverse Vaccinology and Immune Simulation of a Novel Multiepitope Vaccine Targeting Brucella Virulence

  2026cites this paper
• Development of a Novel Polyleucine-Based Immunopotentiator for Subunit Vaccines Against Group A Streptococcus.

  2026cites this paper
• mRNA and Peptide Vaccines in Melanoma-Current Landscape and Future Direction.

  2026cites this paper
• Immunoinformatics-driven multi-epitope vaccine design targeting PSMA, STEAP1, and B7H3 for prostate cancer

  2026cites this paper
• Advances in melanoma immunotherapy: harnessing vaccination as a potential novel immunotherapeutic strategy.

  2026cites this paper
• Recent advances in structural and functional diversities of cancer lncRNA-encoded peptides: current opportunities and challenges for enhancing cancer diagnosis and treatment

  2026cites this paper
• Phytosomes Loaded with Mastoparan-M Represent a Novel Strategy for Breast Cancer Treatment

  2025cites this paper
• Peptide vaccines: an innovative therapeutic approach against antibiotic-resistant bacterial infections

  2025cites this paper
• Lung cancer vaccine strategies: exploring the spectrum from traditional to RNA-based platforms

  2025cites this paper
• PLGA nanoparticles as an efficient carrier in Toxoplasma GAP45: a more effective vaccine against acute toxoplasmosis than traditional ones

  2025cites this paper
• Comprehensive Immunoinformatics Approach for Developing a Multi-Epitope Subunit Vaccine against Lumpy Skin Disease

  2025cites this paper
• Identification of dominant peptide epitopes and antibody response to the spike protein of SARS-CoV-2

  2025cites this paper
• Antimicrobial Peptides Against Arboviruses: Mechanisms, Challenges, and Future Directions

  2025cites this paper
• Development and evaluation of a novel E7 multi-epitopic vaccine for human papillomavirus type 16: design, expression, purification, and immunological characterization

  2025cites this paper
• Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines

  2025cites this paper
• Toxoplasma gondii (GRA10): A Closer Glance Into Immunogenic and Biochemical Characteristics Using In Silico Approach

  2025cites this paper
• Emerging Frontiers in Colorectal Cancer Therapy: From Targeted Molecules to Immunomodulatory Breakthroughs and Cell-Based Approaches

  2025cites this paper
• Peptides on patrol: Carrier systems for targeted delivery.

  2025cites this paper
• Cancer Nanovaccines: Mechanisms, Design Principles, and Clinical Translation

  2025cites this paper
• Engineered MS2 Virus Capsids for Cellular Display of Peptide Antigens

  2025cites this paper
• A Rapid Manual Solid Phase Peptide Synthesis Method for High-Throughput Peptide Production.

  2025cites this paper
• Development of multi-epitope Cathepsin L driven short peptide vaccine against Fasciola gigantica

  2025cites this paper
• Exploring approaches and advancements in the development and evaluation of multi-epitope subunit vaccines against tick-borne viruses.

  2025cites this paper
• In silico screening of epitopes as potential vaccine candidates against pathogenic Acinetobacter baumannii

  2025cites this paper
• Challenges to the Effectiveness and Immunogenicity of COVID-19 Vaccines: A Narrative Review with a Systematic Approach

  2025cites this paper
• Peptide-driven lateral flow platform for detection of classical swine fever viral antigen.

  2025cites this paper
• Neoantigen-Driven Immunotherapy in Triple-Negative Breast Cancer: Emerging Strategies and Clinical Potential

  2025cites this paper
• Identification of T-Cell Epitopes and Vaccine Development for African Swine Fever Virus

  2025cites this paper
• Development and assessment of a peptide vaccine against ovarian cancer utilizing nanoliposomes loaded with P53, WT1, and CA125 epitopes

  2025influential citation
• Prostate Cancer Vaccines: Progress, Challenges, and Future Directions

  2025cites this paper
• A Multi-Epitope Recombinant Vaccine Candidate Against Bovine Alphaherpesvirus 1 and 5 Elicits Robust Immune Responses in Mice and Rabbits

  2025cites this paper
• Influence of component structural arrangement on cholesterol-antigen conjugate immunogenicity and antisera bactericidal activity against group A Streptococcus.

  2025cites this paper
• Investigation of physical mixtures versus disulfide crosslinking self-adjuvanting peptide-based subunit vaccines against Group A Streptococcus.

  2025cites this paper
• Self-Assembled Peptides: A New Generation of Vaccine Adjuvant Platform

  2025cites this paper
• The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences

  2025cites this paper
• Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer

  2025influential citation
• Induction of enhanced stem-directed neutralizing antibodies by HA2-16 ferritin nanoparticles with H3 influenza virus boost

  2025cites this paper
• Microfluidic development of liposome nanoparticles encapsulated with yam polysaccharide.

  2025cites this paper
• Screening helper T lymphocyte epitopes based on IFN-γ/IL-10 ratio for developing a novel multi-epitope vaccine candidate using Wolbachia surface protein as an adjuvant against visceral leishmaniasis

  2025cites this paper
• Novel strategies for targeting tau oligomers in neurodegenerative diseases

  2025cites this paper
• Mycobacterial and monkeypox homologous epitopes: Building blocks of a robust monkeypox vaccine

  2025cites this paper
• FcRn-guided antigen trafficking enhances cancer vaccine efficacy

  2025cites this paper
• Pf-PeptideFilter: An Interactive Catalogue of Peptide Vaccine Candidates for Plasmodium falciparum

  2025cites this paper
• Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile

  2025cites this paper
• Evaluation of novel single-dose vaccine candidates against gonadotropin-releasing hormone (GnRH) in mice.

  2025cites this paper
• Design and Preliminary Immunogenicity Evaluation of Nipah Virus Glycoprotein G Epitope-Based Peptide Vaccine in Mice

  2025cites this paper
• DNA‐Engineered Modular Nanovaccines Featuring Precise Topology for Enhanced Immunogenicity

  2025cites this paper
• Supramolecular Antigen Peptide Nanoparticles for Enhanced Photodynamic Therapy and Immunotherapy against Tumors.

  2025cites this paper
• Reverse vaccinology and immunoinformatics approaches for multi-epitope vaccine design against Klebsiella pneumoniae reveal a novel vaccine target protein

  2025cites this paper
• Integrated in-silico design and in vivo validation of multi-epitope vaccines for norovirus

  2025cites this paper
• Development of an efficacious oral peptide vaccine against infection with the carcinogenic liver fluke Opisthorchis viverrini.

  2025cites this paper
• An immunoinformatics approach in designing high-coverage mRNA multi-epitope vaccine against multivariant SARS-CoV-2

  2025cites this paper
• Development of therapeutic cancer vaccines based on cancer immunity cycle

  2025cites this paper
• Respiratory mucosal vaccines: Applications, delivery strategies and design considerations.

  2025cites this paper
• Design of a Multi-Epitope Vaccine Based on Fasciola gigantica Cathepsin B and Evaluation of Immunological Responses in Mice

  2025cites this paper
• A Milestone in the Shift from “Passive Killing” to “Active Immunomodulation” in Cancer Treatment—Progress in Melanoma Vaccine Research

  2025cites this paper
• Integrating a cationic backbone with a hydrophobic core: A structure-function strategy for designing self-assembling antimicrobial peptides with enhanced activity

  2025cites this paper
• Development of a multi-epitope vaccine candidate targeting conserved regions of human metapneumovirus

  2025cites this paper
• Self-assembled nanoparticle vaccine comprised of multiple epitopes provides robust protective immunity against reoviruses in fish model

  2025cites this paper
• Immunoinformatics-guided vaccine design: A review with case study on Marburg virus.

  2025cites this paper
• Peptide fibrils as a vaccine: Proof of concept.

  2025cites this paper
• Protection of Mice Vaccinated with a New B Cell and T Cell Epitopes Cocktail from Staphylococcus aureus Challenge in Skin Infection Model

  2025cites this paper
• Combination Adjuvants Enhance Recombinant H5 Hemagglutinin Vaccine Protection Against High-Dose Viral Challenge in Chickens

  2024cites this paper
• In silico identification and ex vivo evaluation of Toxoplasma gondii peptides restricted to HLA-A*02, HLA-A*24 and HLA-B*35 alleles in human PBMC from a Colombian population

  2024cites this paper
• Development of a Multiple-Epitope-Based Vaccine for Hepatitis C Virus Genotypes 1a and 1b: an in-silico reverse vaccinology approach

  2024cites this paper
• Personalized cancer vaccine design using AI-powered technologies

  2024cites this paper
• In vivo Immunogenicity and Antigenicity of MAP-8 Peptides Derived from the Structural and Non-Structural Proteins of Canine Parvovirus Type 2

  2024cites this paper
• A multi-epitope self-amplifying mRNA SARS-CoV-2 vaccine design using a reverse vaccinology approach

  2024cites this paper
• Transcutaneous Immunization of 1D Rod-Like Tobacco-Mosaic-Virus-Based Peptide Vaccine via Tip-Loaded Dissolving Microneedles.

  2024cites this paper
• Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies

  2024cites this paper
• Peptide-Purified Anti-N-methyl-D-aspartate Receptor (NMDAR) Autoantibodies Have Inhibitory Effect on Long-Term Synaptic Plasticity

  2024cites this paper
• Identification of three novel linear B-cell epitopes on VP7 of African horse sickness virus using monoclonal antibodies.

  2024cites this paper
• In silico and in vitro evaluation of the immunogenic potential of Leishmania donovani ascorbate peroxidase and its derived peptides.

  2024cites this paper
• Design of a novel EmTSP-3 and EmTIP based multi-epitope vaccine against Echinococcus multilocularis infection

  2024cites this paper
• A modular self-assembling and self-adjuvanting multiepitope peptide nanoparticle vaccine platform to improve the efficacy and immunogenicity of BCG

  2024cites this paper
• Peptibodies: Bridging the gap between peptides and antibodies.

  2024cites this paper
• Components, Formulations, Deliveries, and Combinations of Tumor Vaccines.

  2024cites this paper
• Characterization of Synthetic Peptides by Mass Spectrometry.

  2024cites this paper
• Expression, Purification, and Evaluation of Antibody Responses and Antibody-Immunogen Complex Simulation of a Designed Multi-Epitope Vaccine against SARS-COV-2.

  2024cites this paper
• A broad-spectrum multiepitope vaccine against seasonal influenza A and B viruses in mice

  2024cites this paper
• Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective

  2024cites this paper
• Targeting Yezo Virus Structural Proteins for Multi-Epitope Vaccine Design Using Immunoinformatics Approach

  2024cites this paper
• Immunoinformatic approach to design an efficient multi‐epitope peptide vaccine against melanoma

  2024cites this paper
• Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy.

  2024cites this paper
• 21st century Latin American synthetic peptides for their application in antivenom production

  2024cites this paper
• Self-Assembling Peptides for Vaccine Adjuvant Discovery

  2024cites this paper
• RABV antigenic peptide loaded polymeric nanoparticle production, characterization, and preliminary investigation of its biological activity

  2024cites this paper
• Peptide-based therapeutics targeting genetic disorders.

  2024cites this paper
• Editorial: Peptides against infectious diseases: from antimicrobial peptides to vaccines

  2024cites this paper
• Extracellular vesicles powered cancer immunotherapy: Targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model.

  2024cites this paper
• Next-Generation Dengue Vaccines: Leveraging Peptide-Based Immunogens and Advanced Nanoparticles as Delivery Platforms.

  2024cites this paper
• Advances of computational methods enhance the development of multi-epitope vaccines

  2024cites this paper
• COVID-19 Variants and Vaccine Development

  2024cites this paper
• Current Progress in the Science of Novel Adjuvant Nano-Vaccine-Induced Protective Immune Responses

  2024cites this paper
• Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses

  2024cites this paper
• Generation of Broad Protection against Influenza with Di-Tyrosine-Cross-Linked M2e Nanoclusters.

  2024cites this paper
• Decoding bovine coronavirus immune targets: an epitope informatics approach

  2024cites this paper
• Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy

  2024cites this paper